You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

Citation Tools

Article menu
Emerging technologies, pharmacology and therapeutics
Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Desouza C, Kirk AR, Mangla KK, et al
Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)
BMJ Open Diabetes Research and Care 2020;8:e001830. doi: 10.1136/bmjdrc-2020-001830